Causes of Lymphocytosis
Lymphocytosis has both benign and malignant causes, with viral infections (particularly EBV and CMV) being the most common benign triggers, while chronic lymphocytic leukemia (CLL) and lymphomas represent the primary malignant etiologies 1.
Infectious Causes
Viral infections are the most frequent triggers of reactive lymphocytosis:
- Epstein-Barr virus (EBV) - most common viral cause
- Cytomegalovirus (CMV)
- Other childhood viral illnesses 2
These infections typically produce a pleomorphic lymphocytosis with varied lymphocyte morphology, distinguishing them from malignant causes 3.
Bacterial and fungal infections can also cause lymphocytosis, particularly in immunocompromised patients receiving chemotherapy 1.
Malignant Causes
Hematologic Malignancies
Chronic Lymphocytic Leukemia (CLL) is the most common malignant cause in adults:
- Characterized by monomorphic small lymphocytes with clumped chromatin
- Absolute lymphocyte count typically >5 × 10⁹/L (often much higher)
- Presence of monoclonal B-cell population on flow cytometry 4
Lymphomas that commonly present with lymphocytosis 1:
- T-cell and NK-cell lymphomas/leukemias (35% of malignancy-associated cases)
- Diffuse large B-cell lymphoma (DLBCL) (32% of cases, predominant in Western countries)
- Hodgkin lymphoma (6% of cases)
Acute leukemias may present with circulating blast cells rather than mature lymphocytosis 3.
Autoimmune and Inflammatory Conditions
- Autoimmune diseases can trigger reactive lymphocytosis
- Immune-mediated hemolytic anemia (IMHA)
- Pure red cell aplasia (PRCA)
- Autoinflammatory conditions 1, 5
Drug-Related Causes
- Certain medications can induce lymphocytosis
- Immunomodulating agents (e.g., lenalidomide) cause tumor flare reaction with transient lymphocytosis 6, 7
- BTK inhibitors (ibrutinib, acalabrutinib) and PI3K inhibitors (idelalisib, duvelisib) cause early lymphocyte mobilization, resulting in transient lymphocytosis that does not indicate disease progression 7
Other Benign Causes
Physiologic stressors can double white blood cell counts within hours 2:
- Surgery
- Exercise
- Trauma
- Emotional stress
Additional benign causes 2:
- Asplenia
- Smoking
- Obesity
- Chronic inflammatory conditions
Key Distinguishing Features
Benign vs. Malignant Differentiation
Benign lymphocytosis characteristics 5:
- Pleomorphic lymphocyte appearance (varied sizes and shapes)
- Organized into lymphoid aggregates in bone marrow
- Predominantly B cells in reactive processes
- Associated with concurrent infection or inflammatory disease
- Younger age in viral infections
Malignant lymphocytosis characteristics 5:
- Monomorphic lymphocyte appearance (uniform cells)
- Diffusely distributed in bone marrow
- May show cleaved or lobulated nuclei
- Predominantly T cells in CLL and thymoma
- Older age (typically >65 years for CLL)
- Presence of clonal population on flow cytometry 3
Clinical Pitfalls
Critical thresholds for evaluation 8:
- Lymphocyte count >10 × 10⁹/L has 95% likelihood of clonal population if persistent
- Lymphocyte count <5 × 10⁹/L has only 14% likelihood of clonal population
- Persistent lymphocytosis (present on repeat testing over 2-3 months) warrants further investigation
Important caveats:
- Absolute lymphocyte count alone should not be used as sole indicator for CLL treatment 4
- In patients with initial lymphocyte counts <30 × 10⁹/L, lymphocyte doubling time should not be used as single parameter for treatment decisions 4
- Exclude other causes (infections, steroid administration) before attributing lymphocytosis to malignancy 9
- Neutrophil-to-lymphocyte ratio helps distinguish reactive from neoplastic causes - lower ratios suggest malignancy 10